You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(603127.SH):昭衍(廣州)新藥研究中心完成設立
格隆匯 01-16 18:50

格隆匯1月16日丨昭衍新藥(603127.SH)公佈,公司於2019年12月11日召開第三屆董事會第十四次會議,審議通過了《關於公司對外投資建設昭衍(廣州)新藥評價中心項目的議案》,並經公司2019年第七次臨時股東大會審議通過。

2020年1月15日,公司完成了全資子公司昭衍(廣州)新藥研究中心有限公司的註冊登記手續並取得了《營業執照》,經營範圍:一般經營項目:藥學研究服務;醫療技術研發;生物醫療技術研究;生物製品檢測;生物技術推廣服務;生物技術開發服務;生物技術諮詢、交流服務;生物技術轉讓服務;技術服務。

許可經營項目:實驗動物生產;臨牀檢驗服務。

昭衍(廣州)新藥研究中心有限公司將作為後續推進昭衍(廣州)新藥評價中心項目的實施主體。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account